Targeting prostate cancer bone metastases.
Logothetis
Christopher
C
Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. clogothetis@mdanderson.org
Tu
Shi-Ming
SM
Navone
Nora
N
D018943:Anthracyclines / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000503:physiopathology / Q000556:secondary*; D018450:Disease Progression; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D013326:Strontium Radioisotopes / Q000627:therapeutic use*; D016019:Survival Analysis
D018943:Anthracyclines; D013326:Strontium Radioisotopes